skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 443  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: Breast Cancer Research And Treatment remove subject: Medicine remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Rapid review: radiomics and breast cancer
Rapid review: radiomics and breast cancer
Material Type:
Article 		Add to My Research

Rapid review: radiomics and breast cancer

Breast cancer research and treatment, 2018-06, Vol.169 (2), p.217-229 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2018 ;COPYRIGHT 2018 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-018-4675-4 ;PMID: 29396665

Full text available

Citations Cited by
2
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment
Material Type:
Article 		Add to My Research

Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment

Breast cancer research and treatment, 2021-02, Vol.186 (1), p.219-227 [Peer Reviewed Journal]

The Author(s) 2020 ;COPYRIGHT 2021 Springer ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-020-06001-w ;PMID: 33150548

Full text available

Citations Cited by
3
Granulomatous mastitis: etiology, imaging, pathology, treatment, and clinical findings
Granulomatous mastitis: etiology, imaging, pathology, treatment, and clinical findings
Material Type:
Article 		Add to My Research

Granulomatous mastitis: etiology, imaging, pathology, treatment, and clinical findings

Breast cancer research and treatment, 2018-10, Vol.171 (3), p.527-534 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2018 ;COPYRIGHT 2018 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-018-4870-3 ;PMID: 29971624

Full text available

Citations Cited by
4
Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
Material Type:
Article 		Add to My Research

Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications

Breast cancer research and treatment, 2017-07, Vol.164 (2), p.263-284 [Peer Reviewed Journal]

Springer Science+Business Media New York 2017 ;COPYRIGHT 2017 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, 2017. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-017-4247-z ;PMID: 28444533

Full text available

Citations Cited by
5
Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study
Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study
Material Type:
Article 		Add to My Research

Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study

Breast cancer research and treatment, 2018-06, Vol.169 (3), p.531-536 [Peer Reviewed Journal]

The Author(s) 2018 ;COPYRIGHT 2018 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-018-4709-y ;PMID: 29453521

Full text available

Citations Cited by
6
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Material Type:
Article 		Add to My Research

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

Breast cancer research and treatment, 2010-10, Vol.123 (3), p.725-731 [Peer Reviewed Journal]

Springer Science+Business Media, LLC. 2009 ;2015 INIST-CNRS ;COPYRIGHT 2010 Springer ;Springer Science+Business Media, LLC. 2010 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-009-0674-9 ;PMID: 20020197 ;CODEN: BCTRD6

Full text available

Citations Cited by
7
Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
Material Type:
Article 		Add to My Research

Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy

Breast cancer research and treatment, 2019-07, Vol.176 (2), p.429-434 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2019 ;COPYRIGHT 2019 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-019-05176-1 ;PMID: 30895534

Full text available

Citations Cited by
8
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence
Material Type:
Article 		Add to My Research

Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence

Breast cancer research and treatment, 2020-06, Vol.181 (2), p.391-401 [Peer Reviewed Journal]

The Author(s) 2020 ;COPYRIGHT 2020 Springer ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-020-05638-x ;PMID: 32323103

Full text available

Citations Cited by
9
Loss of HER2 after HER2-targeted treatment
Loss of HER2 after HER2-targeted treatment
Material Type:
Article 		Add to My Research

Loss of HER2 after HER2-targeted treatment

Breast cancer research and treatment, 2019-06, Vol.175 (2), p.401-408 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2019 ;COPYRIGHT 2019 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-019-05173-4 ;PMID: 30806922

Full text available

Citations Cited by
10
Tumor subtypes and survival in male breast cancer
Tumor subtypes and survival in male breast cancer
Material Type:
Article 		Add to My Research

Tumor subtypes and survival in male breast cancer

Breast cancer research and treatment, 2021-08, Vol.188 (3), p.695-702 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 ;COPYRIGHT 2021 Springer ;The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-021-06182-y ;PMID: 33770314

Full text available

Citations Cited by
11
Implications of missing data on reported breast cancer mortality
Implications of missing data on reported breast cancer mortality
Material Type:
Article 		Add to My Research

Implications of missing data on reported breast cancer mortality

Breast cancer research and treatment, 2023-01, Vol.197 (1), p.177-187 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. ;COPYRIGHT 2023 Springer ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-022-06764-4 ;PMID: 36334190

Full text available

Citations Cited by
12
Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response
Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response
Material Type:
Article 		Add to My Research

Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response

Breast cancer research and treatment, 2020-06, Vol.181 (2), p.309-322 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2020 ;COPYRIGHT 2020 Springer ;Springer Science+Business Media, LLC, part of Springer Nature 2020. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-020-05630-5 ;PMID: 32285241

Full text available

Citations Cited by
13
High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy
High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy
Material Type:
Article 		Add to My Research

High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy

Breast cancer research and treatment, 2022-12, Vol.196 (3), p.517-525 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;COPYRIGHT 2022 Springer ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-022-06761-7

Full text available

Citations Cited by
14
Using machine learning to parse breast pathology reports
Using machine learning to parse breast pathology reports
Material Type:
Article 		Add to My Research

Using machine learning to parse breast pathology reports

Breast cancer research and treatment, 2017, Vol.161 (2), p.203-211 [Peer Reviewed Journal]

Springer Science+Business Media New York 2016 ;COPYRIGHT 2017 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, 2017. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-016-4035-1 ;PMID: 27826755 ;CODEN: BCTRD6

Full text available

Citations Cited by
15
Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis
Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis

Breast cancer research and treatment, 2021-04, Vol.186 (3), p.591-605 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 ;COPYRIGHT 2021 Springer ;The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-021-06104-y ;PMID: 33559780

Full text available

Citations Cited by
16
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
Material Type:
Article 		Add to My Research

Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer

Breast cancer research and treatment, 2022-06, Vol.193 (2), p.437-444 [Peer Reviewed Journal]

The Author(s) 2022 ;2022. The Author(s). ;COPYRIGHT 2022 Springer ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-022-06585-5 ;PMID: 35397078

Full text available

Citations Cited by
17
Diagnostic value of radiomics and machine learning with dynamic contrast-enhanced magnetic resonance imaging for patients with atypical ductal hyperplasia in predicting malignant upgrade
Diagnostic value of radiomics and machine learning with dynamic contrast-enhanced magnetic resonance imaging for patients with atypical ductal hyperplasia in predicting malignant upgrade
Material Type:
Article 		Add to My Research

Diagnostic value of radiomics and machine learning with dynamic contrast-enhanced magnetic resonance imaging for patients with atypical ductal hyperplasia in predicting malignant upgrade

Breast cancer research and treatment, 2021-06, Vol.187 (2), p.535-545 [Peer Reviewed Journal]

The Author(s) 2021 ;COPYRIGHT 2021 Springer ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-020-06074-7 ;PMID: 33471237

Full text available

Citations Cited by
18
Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review
Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review
Material Type:
Article 		Add to My Research

Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review

Breast cancer research and treatment, 2018-02, Vol.167 (3), p.615-633 [Peer Reviewed Journal]

Springer Science+Business Media, LLC 2017 ;COPYRIGHT 2018 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-017-4561-5 ;PMID: 29110151

Full text available

Citations Cited by
19
A comparative analysis of recurrence risk predictions in ER+/HER2− early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast
A comparative analysis of recurrence risk predictions in ER+/HER2− early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast
Material Type:
Article 		Add to My Research

A comparative analysis of recurrence risk predictions in ER+/HER2− early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast

Breast cancer research and treatment, 2022-11, Vol.196 (2), p.299-310 [Peer Reviewed Journal]

The Author(s) 2022 ;COPYRIGHT 2022 Springer ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-022-06729-7 ;PMID: 36085534

Full text available

Citations Cited by
20
Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis
Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis
Material Type:
Article 		Add to My Research

Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis

Breast cancer research and treatment, 2021-05, Vol.187 (1), p.275-285 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 ;COPYRIGHT 2021 Springer ;The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-020-06067-6 ;PMID: 33392843

Full text available

Citations Cited by

Results 1 - 20 of 443  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2010  (5)
  2. 2010 To 2012  (28)
  3. 2013 To 2015  (36)
  4. 2016 To 2019  (163)
  5. After 2019  (212)
  6. More options open sub menu

Language 

  1. Japanese  (37)
  2. Norwegian  (1)
  3. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait